L. Kanioura

Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.

M. Arendrup, J. Meletiadis, J. Mouton, 2019, The Journal of antimicrobial chemotherapy.

Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method.

M. Arendrup, J. Guinea, M. Cuenca‐Estrella, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida albicans Using a Validated In Vitro Pharmacokinetic/Pharmacodynamic Model

M. Arendrup, D. Andes, J. Meletiadis, 2020, Antimicrobial Agents and Chemotherapy.

Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.

M. Arendrup, D. Perlin, J. Meletiadis, 2019, The Journal of antimicrobial chemotherapy.

A multicentre study to optimize echinocandin susceptibility testing of Aspergillus species with the EUCAST methodology and a broth microdilution colorimetric method.

M. Arendrup, D. Perlin, J. Meletiadis, 2020, The Journal of antimicrobial chemotherapy.

Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model

A. Peleg, J. Roberts, J. Meletiadis, 2018, The Journal of antimicrobial chemotherapy.